Related references
Note: Only part of the references are listed.Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Aiming for the elimination of viral hepatitis in Australia, New Zealand, and the Pacific Islands and Territories: Where are we now and barriers to meeting World Health Organization targets by 2030
Jess Howell et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Hepatocellular carcinoma in Australia 1982-2014: Increasing incidence and improving survival
Michael C. Wallace et al.
LIVER INTERNATIONAL (2019)
Stereotactic body radiation therapy for early-stage hepatocellular carcinoma - a systematic review on outcome
M. Dobrzycka et al.
ACTA ONCOLOGICA (2019)
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
Jens Ricke et al.
JOURNAL OF HEPATOLOGY (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis
Lewis R. Roberts et al.
HEPATOLOGY (2018)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
Vincenzo Mazzaferro et al.
GASTROENTEROLOGY (2018)
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
Pierce K. H. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion A Randomized Clinical Trial
Sang Min Yoon et al.
JAMA ONCOLOGY (2018)
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
Fasiha Kanwal et al.
GASTROENTEROLOGY (2018)
Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study
Thai P. Hong et al.
MEDICAL JOURNAL OF AUSTRALIA (2018)
Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survival
Stuart K. Roberts et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valerie Vilgrain et al.
LANCET ONCOLOGY (2017)
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
Tim Meyer et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature
Brindha Pillay et al.
CANCER TREATMENT REVIEWS (2016)
Novel Population-Based Study Finding Higher Than Reported Hepatocellular Carcinoma Incidence Suggests an Updated Approach Is Needed
Thai P. Hong et al.
HEPATOLOGY (2016)
Risk of Hepatocellular Carcinoma After Sustained Virological Response in Veterans With Hepatitis C Virus Infection
Hashem B. El-Serag et al.
HEPATOLOGY (2016)
Image-guided ablation of primary liver and renal tumours
David J. Breen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Establishment of a Multidisciplinary Hepatocellular Carcinoma Clinic is Associated with Improved Clinical Outcome
Adam C. Yopp et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Hepatocellular carcinoma in Australia's Northern Territory: high incidence and poor outcome
Christopher Parker et al.
MEDICAL JOURNAL OF AUSTRALIA (2014)
CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma. Part II. Extracellular Agents, Hepatobiliary Agents, and Ancillary Imaging Features
Jin-Young Choi et al.
RADIOLOGY (2014)
Chronic hepatitis B prevalence among Aboriginal and Torres Strait Islander Australians since universal vaccination: a systematic review and meta-analysis
Simon Graham et al.
BMC INFECTIOUS DISEASES (2013)
Hepatocellular Carcinoma: Resection versus Transplantation
Truman M. Earl et al.
SEMINARS IN LIVER DISEASE (2013)
Analgesics in Patients with Hepatic Impairment Pharmacology and Clinical Implications
Marija Bosilkovska et al.
DRUGS (2012)
Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies
Chenggang Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Liver cancer is the fastest increasing cause of cancer death in Australians
Jennifer H. MacLachlan et al.
MEDICAL JOURNAL OF AUSTRALIA (2012)
LI-RADS: A Case-based Review of the New Categorization of Liver Findings in Patients with End-Stage Liver Disease
Andrei S. Purysko et al.
RADIOGRAPHICS (2012)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence
D. Saunders et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
A Meta-Analysis of Survival Rates of Untreated Patients in Randomized Clinical Trials of Hepatocellular Carcinoma
Giuseppe Cabibbo et al.
HEPATOLOGY (2010)
AGREE II: Advancing guideline development, reporting and evaluation in health care
Melissa C. Brouwers et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2010)
Microwave coagulation therapy for hepatic tumors: Review of the literature and critical analysis
C. Boutros et al.
SURGICAL ONCOLOGY-OXFORD (2010)
Systematic Review of Randomized Trials for Hepatocellular Carcinoma Treated with Percutaneous Ablation Therapies
Yun Ku Cho et al.
HEPATOLOGY (2009)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies
S. C. Larsson et al.
BRITISH JOURNAL OF CANCER (2007)
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
JM Llovet et al.
HEPATOLOGY (2003)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
The role of diabetes in hepatocellular carcinoma: A case-control study among United States veterans
HB El-Serag et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2001)
Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
FY Yao et al.
HEPATOLOGY (2001)
Share Paper
